<SEC-DOCUMENT>0001213900-25-079602-index.html : 20250822 <SEC-HEADER>0001213900-25-079602.hdr.sgml : 20250822 <ACCEPTANCE-DATETIME>20250822091610 ACCESSION NUMBER: 0001213900-25-079602 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20250822 FILED AS OF DATE: 20250822 DATE AS OF CHANGE: 20250822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AKANDA CORP. CENTRAL INDEX KEY: 0001888014 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41324 FILM NUMBER: 251242452 BUSINESS ADDRESS: STREET 1: 1A, 1B LEAROYD ROAD CITY: NEW ROMNEY STATE: X0 ZIP: TN28 8XU BUSINESS PHONE: 442034889514 MAIL ADDRESS: STREET 1: 77 KING STREET WEST, SUITE 400 STREET 2: C/O DENTONS CANADA LLP CITY: TORONTO STATE: A6 ZIP: M5K 0A1 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>ea0254212-6k_akanda.htm <DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER <TEXT> Document 1 - file: ea0254212-6k_akanda.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ea025421201ex99-1_akanda.htm <DESCRIPTION>PRESS RELEASE, DATED AUGUST 22, 2025, ANNOUNCING SHARE CONSOLIDATION <TEXT> Document 2 - file: ea025421201ex99-1_akanda.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>ea025421201ex99-2_akanda.htm <DESCRIPTION>ARTICLES AND CERTIFICATE OF AMENDMENT OF AKANDA CORP <TEXT> Document 3 - file: ea025421201ex99-2_akanda.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ex99-2_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: ex99-2_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ex99-2_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: ex99-2_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ex99-2_003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: ex99-2_003.jpg
</DOCUMENT> </SEC-DOCUMENT>